Mannucci P M
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Medicine and Medical Specialties, University of Milan, Italy.
Haemophilia. 2008 Jan;14 Suppl 1:1-4. doi: 10.1111/j.1365-2516.2007.01609.x.
This review summarizes the steps that led to the development of desmopressin as a hemostatic agent. This drug has broadened the panel of pharmacological agents that can be used to treat or prevent bleeding in patients with mild hemophilia and von Willebrand disease.
本综述总结了去氨加压素作为一种止血剂的研发历程。这种药物拓宽了可用于治疗或预防轻度血友病和血管性血友病患者出血的药物种类。